{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:11:58Z","timestamp":1791583918390,"version":"4.3.4"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004572","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","award":["2017ZX10304402001-008"],"award-info":[{"award-number":["2017ZX10304402001-008"]}],"id":[{"id":"10.13039\/501100004572","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81722007"],"award-info":[{"award-number":["81722007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070231"],"award-info":[{"award-number":["82070231"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.yjmcc.2021.06.011","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T09:11:52Z","timestamp":1624525912000},"page":"120-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Function of histone methylation and acetylation modifiers in cardiac hypertrophy"],"prefix":"10.1016","volume":"159","author":[{"given":"Jian","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"30","key":"10.1016\/j.yjmcc.2021.06.011_bb0005","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1093\/eurheartj\/ehx343","article-title":"Cardiomyocyte renewal in the human heart: insights from the fall-out","volume":"38","author":"Lazar","year":"2017","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.yjmcc.2021.06.011_bb0010","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ. Res."},{"issue":"13","key":"10.1016\/j.yjmcc.2021.06.011_bb0015","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJMra072139","article-title":"Cardiac plasticity","volume":"358","author":"Hill","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.yjmcc.2021.06.011_bb0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"13","key":"10.1016\/j.yjmcc.2021.06.011_bb0025","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1042\/CS20160170","article-title":"Molecular mechanisms in cardiomyopathy","volume":"131","author":"Dadson","year":"2017","journal-title":"Clin. Sci. (Lond.)"},{"issue":"5795","key":"10.1016\/j.yjmcc.2021.06.011_bb0030","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1126\/science.1132292","article-title":"Gene regulatory networks in the evolution and development of the heart","volume":"313","author":"Olson","year":"2006","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.yjmcc.2021.06.011_bb0035","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1161\/CIRCRESAHA.111.249433","article-title":"Analysis of transcriptome complexity through RNA sequencing in normal and failing murine hearts","volume":"109","author":"Lee","year":"2011","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.06.011_bb0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1172\/JCI84015","article-title":"RBFox1-mediated RNA splicing regulates cardiac hypertrophy and heart failure","volume":"126","author":"Gao","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.yjmcc.2021.06.011_bb0045","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1152\/physrev.00007.2019","article-title":"mRNA metabolism in cardiac development and disease: life after transcription","volume":"100","author":"Gao","year":"2020","journal-title":"Physiol. Rev."},{"issue":"Suppl F","key":"10.1016\/j.yjmcc.2021.06.011_bb0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/eurheartj\/5.suppl_F.181","article-title":"Cardiac myosin heavy chain isozymic transitions during development and under pathological conditions are regulated at the level of mRNA availability","volume":"5","author":"Mahdavi","year":"1984","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.yjmcc.2021.06.011_bb0055","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/01.RES.0000072977.86706.23","article-title":"Roles of cardiac transcription factors in cardiac hypertrophy","volume":"92","author":"Akazawa","year":"2003","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.yjmcc.2021.06.011_bb0060","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1161\/CIRCRESAHA.118.311597","article-title":"Epigenomes in cardiovascular disease","volume":"122","author":"Rosa-Garrido","year":"2018","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2021.06.011_bb0065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.tem.2019.11.009","article-title":"Metabolism, epigenetics, and causal inference in heart failure","volume":"31","author":"Kimball","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.011_bb0070","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1152\/physrev.00037.2019","article-title":"Role of the epigenome in heart failure","volume":"100","author":"Papait","year":"2020","journal-title":"Physiol. Rev."},{"issue":"6199","key":"10.1016\/j.yjmcc.2021.06.011_bb0075","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1126\/science.1256271","article-title":"Immunogenetics. Chromatin state dynamics during blood formation","volume":"345","author":"Lara-Astiaso","year":"2014","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.yjmcc.2021.06.011_bb0080","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.cell.2013.02.011","article-title":"Chromatin remodeling at DNA double-strand breaks","volume":"152","author":"Price","year":"2013","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.yjmcc.2021.06.011_bb0085","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41580-019-0132-4","article-title":"The role of 3D genome organization in development and cell differentiation","volume":"20","author":"Zheng","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.011_bb0090","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1139\/o05-115","article-title":"Chromatin remodeling complexes: ATP-dependent machines in action","volume":"83","author":"Johnson","year":"2005","journal-title":"Biochem. Cell Biol. Biochim. Biol. Cell."},{"issue":"5532","key":"10.1016\/j.yjmcc.2021.06.011_bb0095","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"Jenuwein","year":"2001","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.011_bb0100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tplants.2006.02.008","article-title":"Chromosomal histone modification patterns--from conservation to diversity","volume":"11","author":"Fuchs","year":"2006","journal-title":"Trends Plant Sci."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.011_bb0105","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2007.01.015","article-title":"The role of chromatin during transcription","volume":"128","author":"Li","year":"2007","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.011_bb0110","doi-asserted-by":"crossref","first-page":"376","DOI":"10.15252\/embj.201593377","article-title":"Touch, act and go: landing and operating on nucleosomes","volume":"35","author":"Speranzini","year":"2016","journal-title":"EMBO J."},{"issue":"7345","key":"10.1016\/j.yjmcc.2021.06.011_bb0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature09906","article-title":"Mapping and analysis of chromatin state dynamics in nine human cell types","volume":"473","author":"Ernst","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.011_bb0120","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cell.2007.05.009","article-title":"High-resolution profiling of histone methylations in the human genome","volume":"129","author":"Barski","year":"2007","journal-title":"Cell"},{"issue":"50","key":"10.1016\/j.yjmcc.2021.06.011_bb0125","doi-asserted-by":"crossref","first-page":"20164","DOI":"10.1073\/pnas.1315155110","article-title":"Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy","volume":"110","author":"Papait","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.yjmcc.2021.06.011_bb0130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ng.1068","article-title":"Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis","volume":"44","author":"Delgado-Olguin","year":"2012","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.yjmcc.2021.06.011_bb0135","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm.4179","article-title":"The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy","volume":"22","author":"Wang","year":"2016","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.06.011_bb0140","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/jcmm.13961","article-title":"NSD2 promotes ventricular remodelling mediated by the regulation of H3K36me2","volume":"23","author":"Zhou","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.06.011_bb0145","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1172\/JCI88353","article-title":"The H3K9 dimethyltransferases EHMT1\/2 protect against pathological cardiac hypertrophy","volume":"127","author":"Thienpont","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"33","key":"10.1016\/j.yjmcc.2021.06.011_bb0150","doi-asserted-by":"crossref","first-page":"E7871","DOI":"10.1073\/pnas.1800680115","article-title":"Histone methyltransferase Smyd1 regulates mitochondrial energetics in the heart","volume":"115","author":"Warren","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.yjmcc.2021.06.011_bb0155","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1172\/JCI46277","article-title":"The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice","volume":"121","author":"Zhang","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.yjmcc.2021.06.011_bb0160","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1161\/ATVBAHA.115.305230","article-title":"Histone Methyltransferase SET1 mediates angiotensin II-induced Endothelin-1 transcription and cardiac hypertrophy in mice","volume":"35","author":"Yu","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yjmcc.2021.06.011_bb0165","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.yjmcc.2015.02.010","article-title":"A crosstalk between chromatin remodeling and histone H3K4 methyltransferase complexes in endothelial cells regulates angiotensin II-induced cardiac hypertrophy","volume":"82","author":"Weng","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"7","key":"10.1016\/j.yjmcc.2021.06.011_bb0170","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1172\/JCI44641","article-title":"Loss of H3K4 methylation destabilizes gene expression patterns and physiological functions in adult murine cardiomyocytes","volume":"121","author":"Stein","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"7302","key":"10.1016\/j.yjmcc.2021.06.011_bb0175","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature09130","article-title":"Chromatin regulation by Brg1 underlies heart muscle development and disease","volume":"466","author":"Hang","year":"2010","journal-title":"Nature"},{"issue":"7520","key":"10.1016\/j.yjmcc.2021.06.011_bb0180","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature13596","article-title":"A long noncoding RNA protects the heart from pathological hypertrophy","volume":"514","author":"Han","year":"2014","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.yjmcc.2021.06.011_bb0185","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1021\/acs.chemrev.8b00008","article-title":"Chemical and biochemical perspectives of protein lysine methylation","volume":"118","author":"Luo","year":"2018","journal-title":"Chem. Rev."},{"issue":"13","key":"10.1016\/j.yjmcc.2021.06.011_bb0190","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/CIRCULATIONAHA.117.028561","article-title":"Histone Methyltransferase G9a is required for cardiomyocyte homeostasis and hypertrophy","volume":"136","author":"Papait","year":"2017","journal-title":"Circulation"},{"issue":"7 Pt B","key":"10.1016\/j.yjmcc.2021.06.011_bb0195","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.bbamcr.2016.03.002","article-title":"Epigenetic response to environmental stress: assembly of BRG1-G9a\/GLP-DNMT3 repressive chromatin complex on Myh6 promoter in pathologically stressed hearts","volume":"1863","author":"Han","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.yjmcc.2021.06.011_bb0200","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/s41419-019-2121-0","article-title":"Kindlin-2 suppresses transcription factor GATA4 through interaction with SUV39H1 to attenuate hypertrophy","volume":"10","author":"Qi","year":"2019","journal-title":"Cell Death Dis."},{"issue":"18","key":"10.1016\/j.yjmcc.2021.06.011_bb0205","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1002\/1873-3468.13515","article-title":"Protective effect of histone methyltransferase NSD3 on ISO-induced cardiac hypertrophy","volume":"593","author":"Chen","year":"2019","journal-title":"FEBS Lett."},{"issue":"5595","key":"10.1016\/j.yjmcc.2021.06.011_bb0210","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1076997","article-title":"Role of histone H3 lysine 27 methylation in Polycomb-group silencing","volume":"298","author":"Cao","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.yjmcc.2021.06.011_bb0215","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/CIRCRESAHA.111.252205","article-title":"Polycomb repressive complex 2 regulates normal development of the mouse heart","volume":"110","author":"He","year":"2012","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.yjmcc.2021.06.011_bb0220","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCRESAHA.117.311212","article-title":"Divergent requirements for EZH1 in heart development versus regeneration","volume":"121","author":"Ai","year":"2017","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.011_bb0225","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.bbrc.2013.05.079","article-title":"MicroRNA-214 provokes cardiac hypertrophy via repression of EZH2","volume":"436","author":"Yang","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.yjmcc.2021.06.011_bb0230","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/nar\/gkt896","article-title":"The primary microRNA-208b interacts with Polycomb-group protein, Ezh2, to regulate gene expression in the heart","volume":"42","author":"Mathiyalagan","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"29","key":"10.1016\/j.yjmcc.2021.06.011_bb0235","doi-asserted-by":"crossref","first-page":"47565","DOI":"10.18632\/oncotarget.17735","article-title":"LncRNA TINCR attenuates cardiac hypertrophy by epigenetically silencing CaMKII","volume":"8","author":"Shao","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.yjmcc.2021.06.011_bb0240","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2174\/1566523218666181008125010","article-title":"EZH2 RIP-seq identifies tissue-specific long non-coding RNAs","volume":"18","author":"Wang","year":"2018","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.yjmcc.2021.06.011_bb0245","doi-asserted-by":"crossref","first-page":"585691","DOI":"10.3389\/fcvm.2021.585691","article-title":"EZH2 dynamically associates with non-coding RNAs in mouse hearts after acute angiotensin II treatment","volume":"8","author":"Wang","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"10","key":"10.1016\/j.yjmcc.2021.06.011_bb0250","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.str.2015.07.018","article-title":"Evolving catalytic properties of the MLL family SET domain","volume":"23","author":"Zhang","year":"2015","journal-title":"Structure"},{"key":"10.1016\/j.yjmcc.2021.06.011_bb0255","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2119\/molmed.2017.00012","article-title":"The histone Methyltransferase mixed lineage leukemia (MLL) 3 may play a potential role on clinical dilated cardiomyopathy","volume":"23","author":"Jiang","year":"2017","journal-title":"Mol. Med."},{"issue":"10","key":"10.1016\/j.yjmcc.2021.06.011_bb0260","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc2915","article-title":"Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis","volume":"10","author":"Mohan","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.011_bb0265","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/cdd.2014.199","article-title":"DOT1L-mediated H3K79me2 modification critically regulates gene expression during cardiomyocyte differentiation","volume":"23","author":"Cattaneo","year":"2016","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.yjmcc.2021.06.011_bb0270","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1101\/gad.2018511","article-title":"DOT1L regulates dystrophin expression and is critical for cardiac function","volume":"25","author":"Nguyen","year":"2011","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.06.011_bb0275","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng866","article-title":"Bop encodes a muscle-restricted protein containing MYND and SET domains and is essential for cardiac differentiation and morphogenesis","volume":"31","author":"Gottlieb","year":"2002","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.yjmcc.2021.06.011_bb0280","doi-asserted-by":"crossref","first-page":"H1234","DOI":"10.1152\/ajpheart.00235.2016","article-title":"The chromatin-binding protein Smyd1 restricts adult mammalian heart growth","volume":"311","author":"Franklin","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"10.1016\/j.yjmcc.2021.06.011_bb0285","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrm3327","article-title":"Molecular mechanisms and potential functions of histone demethylases","volume":"13","author":"Kooistra","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.06.011_bb0290","doi-asserted-by":"crossref","DOI":"10.1172\/JCI136488","article-title":"Targeting the histone demethylase LSD1 prevents cardiomyopathy in a mouse model of laminopathy","volume":"131","author":"Guenantin","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.06.011_bb0295","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.1038\/s41467-018-07173-2","article-title":"Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yjmcc.2021.06.011_bb0300","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fphys.2020.00539","article-title":"The histone demethylase JMJD1C regulates CAMKK2-AMPK signaling to participate in cardiac hypertrophy","volume":"11","author":"Yu","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.yjmcc.2021.06.011_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2018.05.009","article-title":"JMJD3 inhibition protects against isoproterenol-induced cardiac hypertrophy by suppressing beta-MHC expression","volume":"477","author":"Guo","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.yjmcc.2021.06.011_bb0310","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrm.2016.140","article-title":"Metabolic regulation of gene expression through histone acylations","volume":"18","author":"Sabari","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.011_bb0315","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.molcel.2016.06.038","article-title":"Diverse activities of histone Acylations connect metabolism to chromatin function","volume":"63","author":"Dutta","year":"2016","journal-title":"Mol. Cell"},{"issue":"10","key":"10.1016\/j.yjmcc.2021.06.011_bb0320","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1128\/MCB.23.10.3593-3606.2003","article-title":"Cardiac p300 is involved in myocyte growth with decompensated heart failure","volume":"23","author":"Yanazume","year":"2003","journal-title":"Mol. Cell. Biol."},{"issue":"9","key":"10.1016\/j.yjmcc.2021.06.011_bb0325","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/CIRCULATIONAHA.107.760488","article-title":"Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300","volume":"118","author":"Wei","year":"2008","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.011_bb0330","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1111\/jcmm.14162","article-title":"Acetyltransferase p300 inhibitor reverses hypertension-induced cardiac fibrosis","volume":"23","author":"Rai","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"5","key":"10.1016\/j.yjmcc.2021.06.011_bb0335","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/CIRCULATIONAHA.105.585182","article-title":"Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo","volume":"113","author":"Miyamoto","year":"2006","journal-title":"Circulation"},{"issue":"1\u20132","key":"10.1016\/j.yjmcc.2021.06.011_bb0340","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1024132217870","article-title":"Biological role of p300 in cardiac myocytes","volume":"248","author":"Yanazume","year":"2003","journal-title":"Mol. Cell. Biochem."},{"issue":"11","key":"10.1016\/j.yjmcc.2021.06.011_bb0345","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1161\/01.CIR.96.11.3943","article-title":"cis-Acting sequences that mediate induction of beta-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction","volume":"96","author":"Hasegawa","year":"1997","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.011_bb0350","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.bbrc.2014.04.112","article-title":"The histone acetyltransferase MOF overexpression blunts cardiac hypertrophy by targeting ROS in mice","volume":"448","author":"Qiao","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.06.011_bb0355","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ydbio.2015.04.011","article-title":"Mesodermal expression of Moz is necessary for cardiac septum development","volume":"403","author":"Vanyai","year":"2015","journal-title":"Dev. Biol."},{"issue":"9","key":"10.1016\/j.yjmcc.2021.06.011_bb0360","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.7150\/ijms.44604","article-title":"Downregulation of P300\/CBP-associated factor attenuates myocardial ischemia-reperfusion injury via inhibiting autophagy","volume":"17","author":"Qiu","year":"2020","journal-title":"Int. J. Med. Sci."},{"issue":"6","key":"10.1016\/j.yjmcc.2021.06.011_bb0365","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.it.2018.02.009","article-title":"Lysine Deacetylases and regulated glycolysis in macrophages","volume":"39","author":"Shakespear","year":"2018","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.011_bb0370","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1152\/physrev.00004.2015","article-title":"Histone Deacetylases in bone development and skeletal disorders","volume":"95","author":"Bradley","year":"2015","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.011_bb0375","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s13311-013-0226-1","article-title":"Small molecule inhibitors of zinc-dependent histone deacetylases","volume":"10","author":"Wagner","year":"2013","journal-title":"Neurotherap. J. Am. Soc. Exp. NeuroTherap."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.06.011_bb0380","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.011_bb0385","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(02)00861-9","article-title":"Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy","volume":"110","author":"Zhang","year":"2002","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.yjmcc.2021.06.011_bb0390","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.RES.0000197782.21444.8f","article-title":"Control of cardiac growth by histone acetylation\/deacetylation","volume":"98","author":"Backs","year":"2006","journal-title":"Circ. Res."},{"issue":"14","key":"10.1016\/j.yjmcc.2021.06.011_bb0395","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1101\/gad.1563807","article-title":"Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility","volume":"21","author":"Montgomery","year":"2007","journal-title":"Genes Dev."},{"issue":"11","key":"10.1016\/j.yjmcc.2021.06.011_bb0400","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/01.RES.0000338570.27156.84","article-title":"Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy","volume":"103","author":"Kee","year":"2008","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2021.06.011_bb0405","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nm1552","article-title":"Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity","volume":"13","author":"Trivedi","year":"2007","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.yjmcc.2021.06.011_bb0410","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1172\/JCI24178","article-title":"Protein kinase cascades in the regulation of cardiac hypertrophy","volume":"115","author":"Dorn","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"21","key":"10.1016\/j.yjmcc.2021.06.011_bb0415","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1161\/CIRCULATIONAHA.110.003665","article-title":"Casein kinase-2alpha1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart","volume":"123","author":"Eom","year":"2011","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.yjmcc.2021.06.011_bb0420","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.114.303429","article-title":"Regulation of acetylation of histone deacetylase 2 by p300\/CBP-associated factor\/histone deacetylase 5 in the development of cardiac hypertrophy","volume":"114","author":"Eom","year":"2014","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.yjmcc.2021.06.011_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0121-2","article-title":"PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart","volume":"50","author":"Yoon","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"13","key":"10.1016\/j.yjmcc.2021.06.011_bb0430","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/cvr\/cvy317","article-title":"Inhibition of heat shock protein 70 blocks the development of cardiac hypertrophy by modulating the phosphorylation of histone deacetylase 2","volume":"115","author":"Yoon","year":"2019","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"10.1016\/j.yjmcc.2021.06.011_bb0435","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1172\/JCI35847","article-title":"Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice","volume":"118","author":"Montgomery","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"39","key":"10.1016\/j.yjmcc.2021.06.011_bb0440","doi-asserted-by":"crossref","first-page":"26484","DOI":"10.1074\/jbc.M803686200","article-title":"Transgenic overexpression of Hdac3 in the heart produces increased postnatal cardiac myocyte proliferation but does not induce hypertrophy","volume":"283","author":"Trivedi","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.yjmcc.2021.06.011_bb0445","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/cvr\/cvu254","article-title":"miR-21-3p regulates cardiac hypertrophic response by targeting histone deacetylase-8","volume":"105","author":"Yan","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2021.06.011_bb0450","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pharmtox-010611-134712","article-title":"Therapeutic potential for HDAC inhibitors in the heart","volume":"52","author":"McKinsey","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"19","key":"10.1016\/j.yjmcc.2021.06.011_bb0455","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1128\/MCB.24.19.8467-8476.2004","article-title":"Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development","volume":"24","author":"Chang","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.yjmcc.2021.06.011_bb0460","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.tcm.2012.12.006","article-title":"HDAC-dependent ventricular remodeling","volume":"23","author":"Xie","year":"2013","journal-title":"Trends Cardiov. Med."},{"issue":"6933","key":"10.1016\/j.yjmcc.2021.06.011_bb0465","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nature01555","article-title":"Sequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2","volume":"422","author":"Han","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2021.06.011_bb0470","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yjmcc.2015.03.010","article-title":"Non-sirtuin histone deacetylases in the control of cardiac aging","volume":"83","author":"Ferguson","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2021.06.011_bb0475","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1152\/japplphysiol.00006.2018","article-title":"Transgenic overexpression of active HDAC4 in the heart attenuates cardiac function and exacerbates remodeling in infarcted myocardium","volume":"125","author":"Zhang","year":"2018","journal-title":"J. Appl. Physiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2021.06.011_bb0480","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1172\/JCI133753","article-title":"Salt-inducible kinase 1 maintains HDAC7 stability to promote pathologic cardiac remodeling","volume":"130","author":"Hsu","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.06.011_bb0485","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.yjmcc.2011.04.005","article-title":"Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension","volume":"51","author":"Lemon","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.yjmcc.2021.06.011_bb0490","doi-asserted-by":"crossref","first-page":"H252","DOI":"10.1152\/ajpheart.00149.2014","article-title":"HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling","volume":"307","author":"Demos-Davies","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"24","key":"10.1016\/j.yjmcc.2021.06.011_bb0495","doi-asserted-by":"crossref","first-page":"10636","DOI":"10.1128\/MCB.24.24.10636-10649.2004","article-title":"The CRM1 nuclear export receptor controls pathological cardiac gene expression","volume":"24","author":"Harrison","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"19","key":"10.1016\/j.yjmcc.2021.06.011_bb0500","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.1128\/MCB.24.19.8374-8385.2004","article-title":"Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5","volume":"24","author":"Vega","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.yjmcc.2021.06.011_bb0505","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.cell.2008.04.041","article-title":"A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy","volume":"133","author":"Ago","year":"2008","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.yjmcc.2021.06.011_bb0510","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bbagrm.2009.04.001","article-title":"Suppression of HDAC nuclear export and cardiomyocyte hypertrophy by novel irreversible inhibitors of CRM1","volume":"1789","author":"Monovich","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.yjmcc.2021.06.011_bb0515","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1172\/JCI27438","article-title":"CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy","volume":"116","author":"Backs","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.yjmcc.2021.06.011_bb0520","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.cmet.2011.10.001","article-title":"PPARalpha-Sirt1 complex mediates cardiac hypertrophy and failure through suppression of the ERR transcriptional pathway","volume":"14","author":"Oka","year":"2011","journal-title":"Cell Metab."},{"issue":"20","key":"10.1016\/j.yjmcc.2021.06.011_bb0525","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1128\/MCB.00426-08","article-title":"SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70","volume":"28","author":"Sundaresan","year":"2008","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.06.011_bb0530","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/HYPERTENSIONAHA.119.13357","article-title":"Cardiomyocyte Sirt (Sirtuin) 7 ameliorates stress-induced cardiac hypertrophy by interacting with and Deacetylating GATA4","volume":"75","author":"Yamamura","year":"2020","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.yjmcc.2021.06.011_bb0535","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/cvr\/cvq376","article-title":"Sirt1 acts in association with PPARalpha to protect the heart from hypertrophy, metabolic dysregulation, and inflammation","volume":"90","author":"Planavila","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.yjmcc.2021.06.011_bb0540","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.RES.0000267723.65696.4a","article-title":"Sirt1 regulates aging and resistance to oxidative stress in the heart","volume":"100","author":"Alcendor","year":"2007","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.011_bb0545","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00395-015-0493-6","article-title":"SIRT3 deficiency impairs mitochondrial and contractile function in the heart","volume":"110","author":"Koentges","year":"2015","journal-title":"Basic Res. Cardiol."},{"issue":"21","key":"10.1016\/j.yjmcc.2021.06.011_bb0550","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.117.028728","article-title":"SIRT2 acts as a Cardioprotective Deacetylase in pathological cardiac hypertrophy","volume":"136","author":"Tang","year":"2017","journal-title":"Circulation"},{"issue":"48","key":"10.1016\/j.yjmcc.2021.06.011_bb0555","doi-asserted-by":"crossref","first-page":"19767","DOI":"10.1074\/jbc.M117.809897","article-title":"Sirtuin 5 is required for mouse survival in response to cardiac pressure overload","volume":"292","author":"Hershberger","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.yjmcc.2021.06.011_bb0560","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/nm.2961","article-title":"The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun","volume":"18","author":"Sundaresan","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.yjmcc.2021.06.011_bb0565","first-page":"96","article-title":"SIRT6 suppresses isoproterenol-induced cardiac hypertrophy through activation of autophagy","volume":"172","author":"Lu","year":"2016","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.06.011_bb0570","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jphs.2016.03.013","article-title":"SIRT6 suppresses phenylephrine-induced cardiomyocyte hypertrophy though inhibiting p300","volume":"132","author":"Shen","year":"2016","journal-title":"J. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.yjmcc.2021.06.011_bb0575","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/FJC.0000000000000404","article-title":"STAT3 suppression is involved in the protective effect of SIRT6 against Cardiomyocyte hypertrophy","volume":"68","author":"Zhang","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"17","key":"10.1016\/j.yjmcc.2021.06.011_bb0580","doi-asserted-by":"crossref","first-page":"9115","DOI":"10.1093\/nar\/gkz648","article-title":"SIRT6 transcriptionally regulates global protein synthesis through transcription factor Sp1 independent of its deacetylase activity","volume":"47","author":"Ravi","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"18","key":"10.1016\/j.yjmcc.2021.06.011_bb0585","first-page":"1389","article-title":"SIRT4 accelerates Ang II-induced pathological cardiac hypertrophy by inhibiting manganese superoxide dismutase activity","volume":"38","author":"Luo","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2021.06.011_bb0590","doi-asserted-by":"crossref","first-page":"110607","DOI":"10.1016\/j.biopha.2020.110607","article-title":"HDAC11: a rising star in epigenetics","volume":"131","author":"Liu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yjmcc.2021.06.011_bb0595","article-title":"HDAC11: a multifaceted histone deacetylase with proficient fatty deacylase activity and its roles in physiological processes","author":"Nunez-Alvarez","year":"2021","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.yjmcc.2021.06.011_bb0600","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.bbrc.2018.04.090","article-title":"HDAC11 deletion reduces fructose-induced cardiac dyslipidemia, apoptosis and inflammation by attenuating oxidative stress injury","volume":"503","author":"Fan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2021.06.011_bb0605","article-title":"The role and molecular mechanism of epigenetics in cardiac hypertrophy","author":"Lei","year":"2020","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.yjmcc.2021.06.011_bb0610","doi-asserted-by":"crossref","first-page":"39752","DOI":"10.1038\/srep39752","article-title":"The histone 3 lysine 9 methyltransferase inhibitor chaetocin improves prognosis in a rat model of high salt diet-induced heart failure","volume":"7","author":"Ono","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yjmcc.2021.06.011_bb0615","first-page":"9174926","article-title":"EZH2 inhibition ameliorates transverse aortic constriction-induced pulmonary arterial hypertension in mice","volume":"2018","author":"Shi","year":"2018","journal-title":"Can. Respir. J."},{"issue":"6","key":"10.1016\/j.yjmcc.2021.06.011_bb0620","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/1947601911417976","article-title":"Targeting histone Demethylases: a new avenue for the fight against Cancer","volume":"2","author":"Rotili","year":"2011","journal-title":"Genes Cancer"},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.011_bb0625","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/10799893.2020.1734819","article-title":"Inhibition of histone demethylase JMJD1C attenuates cardiac hypertrophy and fibrosis induced by angiotensin II","volume":"40","author":"Zhang","year":"2020","journal-title":"J. Recept. Signal Transduct. Res."},{"issue":"6","key":"10.1016\/j.yjmcc.2021.06.011_bb0630","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1172\/JCI19137","article-title":"Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein hop","volume":"112","author":"Kook","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"31","key":"10.1016\/j.yjmcc.2021.06.011_bb0635","doi-asserted-by":"crossref","first-page":"28930","DOI":"10.1074\/jbc.M303113200","article-title":"Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors","volume":"278","author":"Antos","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.yjmcc.2021.06.011_bb0640","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/1440-1681.13022","article-title":"Upregulation of C\/EBPbeta and TSC2 by an HDAC inhibitor CG200745 protects heart from DOCA-induced hypertrophy","volume":"46","author":"Lee","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.011_bb0645","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCULATIONAHA.112.103176","article-title":"Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid","volume":"126","author":"Zhao","year":"2012","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.yjmcc.2021.06.011_bb0650","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1253\/circj.CJ-09-0580","article-title":"Sodium valproate, a histone deacetylase inhibitor, but not captopril, prevents right ventricular hypertrophy in rats","volume":"74","author":"Cho","year":"2010","journal-title":"Circ. J."},{"issue":"3","key":"10.1016\/j.yjmcc.2021.06.011_bb0655","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/cvr\/cvn215","article-title":"Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure","volume":"80","author":"Gallo","year":"2008","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2021.06.011_bb0660","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.105.559724","article-title":"Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding","volume":"113","author":"Kee","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.yjmcc.2021.06.011_bb0665","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1161\/CIRCULATIONAHA.114.013339","article-title":"Restoration of impaired endothelial myocyte enhancer factor 2 function rescues pulmonary arterial hypertension","volume":"131","author":"Kim","year":"2015","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.yjmcc.2021.06.011_bb0670","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1139\/cjpp-2016-0542","article-title":"Selective inhibition of HDAC2 by magnesium valproate attenuates cardiac hypertrophy","volume":"95","author":"Raghunathan","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"10","key":"10.1016\/j.yjmcc.2021.06.011_bb0675","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1164\/rccm.201007-1106OC","article-title":"Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats","volume":"183","author":"Bogaard","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.yjmcc.2021.06.011_bb0680","first-page":"237","article-title":"Histone deacetylase inhibition with trichostatin A does not reverse severe angioproliferative pulmonary hypertension in rats (2013 Grover conference series)","volume":"4","author":"De Raaf","year":"2014","journal-title":"Pulmon. Circ."},{"issue":"3","key":"10.1016\/j.yjmcc.2021.06.011_bb0685","first-page":"868","article-title":"The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats","volume":"118","author":"Morimoto","year":"2008","journal-title":"J. Clin. Invest."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282821001334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282821001334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:00:52Z","timestamp":1762668052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282821001334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":137,"alternative-id":["S0022282821001334"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2021.06.011","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Function of histone methylation and acetylation modifiers in cardiac hypertrophy","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2021.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}